rs1173771 — NPR3 NPR3 promoter variant

NPR3 — The Clearance Valve That Sets Your Blood Pressure

Your blood pressure is governed in part by a family of hormones called natriuretic peptides¹¹ natriuretic peptides
ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) — released by heart muscle cells in response to stretch when blood volume rises. These peptides act on blood vessel walls and kidneys to promote vasodilation and sodium excretion, pulling blood pressure back down. But natriuretic peptides need a mechanism to be cleared from the bloodstream — otherwise their blood-pressure-lowering signal would never switch off.

That clearance role belongs to NPR3, the natriuretic peptide receptor C gene. NPR3 encodes a decoy receptor on vascular smooth muscle and endothelial cells that binds ANP and BNP and internalizes them for degradation — functioning as a physiological "off switch" for natriuretic peptide signaling. When NPR3 is highly expressed, natriuretic peptides are cleared rapidly, reducing their protective vasodilatory signal. When NPR3 is lower, peptides linger in circulation longer, sustaining blood pressure reduction.

The variant rs1173771 sits near the NPR3 transcription start site²² transcription start site
the region of DNA from which gene expression is initiated and reached genome-wide significance for systolic blood pressure, diastolic blood pressure, pulse pressure, and hypertension in the ICBP meta-analysis³³ ICBP meta-analysis
International Consortium for Blood Pressure, combining data from ~200,000 individuals of European descent. The G allele is the BP-elevating allele.

The Mechanism

Functional studies show that the BP-elevating haplotype tagged by rs1173771 is associated with lower endogenous NPR3 mRNA and protein in vascular smooth muscle cells (VSMCs)⁴⁴ lower endogenous NPR3 mRNA and protein in vascular smooth muscle cells (VSMCs)
detected in primary human VSMCs from carriers of the BP-elevating allele vs. the protective allele, along with reduced open chromatin and nuclear protein binding at the locus. In other words, the G allele reduces NPR3 expression — but paradoxically, lower NPR3 means less clearance of vasodilatory natriuretic peptides. The key is that the downstream consequences go beyond simple clearance.

Lower NPR3 expression in VSMCs produces three compounding effects: increased cell proliferation⁵⁵ increased cell proliferation
partially reversible by natriuretic peptide treatment, linking genotype to atherogenic smooth muscle behavior, enhanced angiotensin II-induced intracellular calcium flux⁶⁶ angiotensin II-induced intracellular calcium flux
a molecular signature of heightened vasoconstriction responsiveness, and increased VSMC contraction. The net result is a vascular phenotype primed for higher resting blood pressure and greater pressor responses.

A 2024 experimental model using Dahl salt-sensitive rats⁷⁷ 2024 experimental model using Dahl salt-sensitive rats
Dahl SS rats are a classic model of salt-sensitive hypertension reinforced this picture: when researchers deleted the orthologous noncoding haplotype region, NPR3 was upregulated in arteries and salt-induced systolic blood pressure rose by approximately 10 mmHg less than in unedited controls. The 2025 renal chromatin study⁸⁸ 2025 renal chromatin study
Mapping of ATAC-seq accessible chromatin in human proximal tubule and medullary thick ascending limb segments found rs1173771 enriched within regulatory chromatin in kidney segments that control sodium-water balance, extending the relevant tissue context from vessels to kidney.

The Evidence

The core blood pressure association is established and multiply replicated⁹⁹ established and multiply replicated
GWAS Catalog accessions GCST001227, GCST001228, GCST001235, GCST001236, GCST001238. In the original ICBP meta-analysis, the G allele reached P=2×10⁻¹⁶ for systolic BP (beta +0.50 mmHg per allele) and P=9×10⁻¹² for diastolic BP (beta +0.26 mmHg), P=3×10⁻¹⁰ for hypertension (OR 1.06 per allele).

The effect is small per allele but has been replicated transethnic across European and East Asian populations. A 2013 transethnic meta-analysis¹⁰¹⁰ 2013 transethnic meta-analysis
East Asian stage 1 n=26,600, stage 2 up to 28,783 participants confirmed rs1173771 shows suggestive replication (P=0.018) for mean arterial pressure with consistent effect direction across ancestries. The Genetics of Postural Hemodynamics (GPH) Consortium study¹¹¹¹ Genetics of Postural Hemodynamics (GPH) Consortium study
Published Eur Heart J 2012 found that the A allele was modestly protective against orthostatic hypotension (OR 0.92, 95% CI 0.87–0.98, P=0.009), consistent with the G allele being the BP-elevating variant.

The functional work by Ren et al. (2018) bridges the statistical association to mechanism: using primary human VSMCs genotyped at rs1173771, they demonstrated allele-specific differences in NPR3 expression and downstream vascular cell behavior, elevating this from a statistical GWAS hit to a biologically understood variant.

Practical Actions

The per-allele blood pressure effect (~0.5 mmHg SBP per G allele) is modest in isolation. GG homozygotes carry the full additive effect (~1 mmHg SBP higher than AA), which over a lifetime can compound with other risk factors. The critical question is whether blood pressure lands in the normal, elevated, or hypertensive range in the context of your full genetic and lifestyle profile.

The most important practical implication is monitoring: home blood pressure measurement provides personalized data that genetic risk estimates cannot. If blood pressure trends upward — even into the high-normal range (120–129/80 mmHg) — early lifestyle and dietary intervention is more effective than waiting for overt hypertension to develop.

Dietary sodium is particularly relevant: the NPR3 pathway is central to sodium excretion and fluid balance. Excess dietary sodium blunts natriuretic peptide effectiveness, compounding the reduced clearance capacity created by lower NPR3 expression.

Interactions

rs1173771 is part of a 17.4 kb haplotype block at the NPR3 locus containing 11 SNPs. The sentinel variant rs1173771 tags this haplotype, and the entire block functions as a regulatory unit. Other SNPs in the NPR3 gene region — including rs2270915¹²¹² rs2270915
a previously studied NPR3 promoter polymorphism associated with blood pressure in type 2 diabetes — may have partially overlapping or independent effects. Other blood-pressure GWAS loci in the natriuretic peptide pathway include NPPA/NPPB (ANP and BNP precursor genes) and NPPB itself; collectively, variation across the natriuretic peptide system accumulates to influence resting blood pressure trajectory.